default author photo

Chris Labaki

Harvard University - Lank Center for Genitourinary Oncology

Boston, Massachusetts

United States

SCHOLARLY PAPERS

3

DOWNLOADS

279

TOTAL CITATIONS

3

Scholarly Papers (3)

1.

HLA-A*03 is a Predictive Biomarker of Poor Response to Immune Checkpoint Blockade in Cancer

Number of pages: 26 Posted: 06 May 2021
University of Oxford - Nuffield Department of Medicine, Government of the United States of America - Frederick National Laboratory for Cancer Research, Government of the United States of America - Laboratory of Translational Genomics, Harvard University - Division of Population Sciences, Harvard University - Massachusetts General Hospital, Harvard University - Lank Center for Genitourinary Oncology, Harvard University - Massachusetts General Hospital, Government of the United States of America - Frederick National Laboratory for Cancer Research, EMD Serono Research & Development Institute - Bioinformatics, Department of Translational Medicine, Harvard University - Dana-Farber Cancer Institute, Bristol Myers Squibb, Pfizer, Inc. - Computational Biology, Pfizer, Inc. - Translational Oncology, Harvard University - Division of Population Sciences, Harvard University - Lank Center for Genitourinary Oncology, National Institutes of Health (NIH) - Clinical Immunotherapy Section and National Cancer Institute - Basic Science Program
Downloads 113 (626,371)

Abstract:

Loading...

2.

Breakthrough SARS-CoV-2 Infections Among Patients with Cancer Following Two and Three Doses of COVID-19 mRNA Vaccines

Number of pages: 20 Posted: 21 Apr 2022
Harvard University - Lank Center for Genitourinary Oncology, Harvard University - Lank Center for Genitourinary Oncology, Harvard University - Dana-Farber Cancer Institute, Vanderbilt University - Department of Biostatistics, Harvard University - Dana-Farber Cancer Institute, University of Miami - Sylvester Comprehensive Cancer Center, Henry Ford Health System - Division of Hematology and Medical Oncology, Henry Ford Health System - Division of Hematology and Medical Oncology, Harvard University - Mount Auburn Hospital, Harvard University - Mount Auburn Hospital, Roswell Park Comprehensive Cancer Center, Duke University - Medical Center, Hartford HealthCare Cancer Institute, Loyola University of Chicago - Cardinal Bernardin Cancer Center, Loyola University of Chicago - Cardinal Bernardin Cancer Center, University of Cincinnati - University of Cincinnati Cancer Center, Brown University - Warren Alpert Medical School, Brown University - Warren Alpert Medical School, Penn State Cancer Institute, McGill University - McGill University Health Centre, Geisinger Health System, Northwest Medical Specialties, Medical College of Wisconsin, Medical College of Wisconsin, University of California, San Diego (UCSD) - Moores Cancer Center, University of California, San Diego (UCSD) - Moores Cancer Center, Yeshiva University - Montefiore Medical Center, University of North Carolina (UNC) at Chapel Hill, Virtua Health, UPMC Western Maryland, Holden Comprehensive Cancer Center, Missouri Baptist Medical Center - Cancer Center, St. Joseph's/Candler Health System, Inc., Stamford Hospital, Tallahassee Memorial HealthCare, Medical University of South Carolina, Columbia University - Herbert Irving Comprehensive Cancer Center, Government of the United States of America - Food and Drug Administration (FDA), University of Michigan at Ann Arbor - Rogel Cancer Center, Vanderbilt University - Vanderbilt-Ingram Cancer Center, Government of the United States of America - Food and Drug Administration (FDA), Vanderbilt University - Department of Biostatistics, Brown University - Warren Alpert Medical School and Vanderbilt University - Vanderbilt-Ingram Cancer Center
Downloads 112 (630,858)
Citation 3

Abstract:

Loading...

COVID-19, vaccination, SARS-CoV-2, Cancer

3.

Integrated Clinico-Genomic Analysis of Genetic Ancestry in 1,614 Patients With Cancer Treated With Immune Checkpoint Inhibitors

Number of pages: 57 Posted: 11 Feb 2022
Harvard University - Lank Center for Genitourinary Oncology, Harvard University - Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute - Lank Center for Genitourinary Oncology, Harvard University - Lank Center for Genitourinary Oncology, Harvard University - Division of Population Sciences, Harvard University - Department of Medicine, Harvard University - Lank Center for Genitourinary Oncology, Mount Sinai Health System - Division of Hematology and Medical Oncology, Harvard University - Center for Prevention of Progression of Blood Cancers, Harvard University - Department of Urologic Surgery, Harvard University - Lank Center for Genitourinary Oncology, Harvard University - Lank Center for Genitourinary Oncology, Harvard University - Lank Center for Genitourinary Oncology, Harvard University - Department of Medical Oncology, Harvard University - Department of Radiation Oncology, Harvard University - Department of Medical Oncology, Harvard University - Melanoma Center, Harvard University - Department of Pathology, Harvard University - Department of Data Science, Harvard University - Department of Medicine, Harvard University - Lank Center for Genitourinary Oncology, Harvard University - Division of Genetics and Harvard University - Division of Population Sciences
Downloads 54 (1,020,567)

Abstract:

Loading...

Genetic ancestry, cancer, Immunotherapy, immune checkpoint inhibitors